Scribble

ABT Stock Quote Price and Forecast | CNN

ABT

Abbott Laboratories

Key terms

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Key terms

Smart score

Nov 25 12:15pm ET Strategic Initiatives and Innovations Drive Buy Rating for Abbott Laboratories by TipRanks Nov 20 4:57am ET Wells Fargo Reaffirms Their Buy Rating on Abbott Laboratories (ABT) by TipRanks Nov 19 12:45pm ET Trump Trade: President-elect seeks to kill Biden fuel-efficiency rules by TipRanks Nov 17 9:36am ET Wells Fargo Sticks to Its Buy Rating for Abbott Laboratories (ABT) by TipRanks Nov 05 5:35am ET Abbott price target raised to $149 from $143 at Barclays by TipRanks Nov 04 7:26am ET Abbott price target raised to $149 from $143 at Barclays by TipRanks Nov 04 6:46am ET Abbott Laboratories’ Legal Victory Strengthens Future Outlook and Supports Buy Rating by TipRanks Nov 01 9:48am ET Reckitt and Abbott Shares Rally on Baby Formula Lawsuit Win by TipRanks Nov 01 8:55am ET Morning Movers: Apple dips, Amazon gains after earnings by TipRanks Nov 01 8:12am ET Oppenheimer Sticks to Their Buy Rating for Abbott Laboratories (ABT) by TipRanks Nov 01 7:55am ET Abbott, Mead Johnson secure win in infant formula trial, Reuters reports by TipRanks Nov 01 6:29am ET Abbott Laboratories (ABT) Gets a Buy from Piper Sandler by TipRanks Nov 01 5:20am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (BMY), Abbott Laboratories (ABT) and Merck & Company (MRK) by TipRanks Oct 30 10:20pm ET Analysts Are Bullish on These Healthcare Stocks: United Therapeutics (UTHR), Abbott Laboratories (ABT) by TipRanks Oct 30 10:20pm ET Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT) by TipRanks Oct 30 7:45am ET Abbott Laboratories (ABT) Gets a Buy from TD Cowen by TipRanks Oct 28 2:25pm ET Raymond James says Edwards’ EARLY TAVR data also positive for Medtronic, Abbott by TipRanks Oct 24 9:10am ET Abbott initiates clinical trial of its CardioMems in advanced heart failure by TipRanks Oct 17 8:36am ET Abbott price target raised to $130 from $115 at Mizuho by TipRanks Oct 17 8:08am ET Citi Keeps Their Buy Rating on Abbott Laboratories (ABT) by TipRanks Oct 17 8:05am ET Oppenheimer Reaffirms Their Buy Rating on Abbott Laboratories (ABT) by TipRanks Oct 17 7:30am ET Abbott price target raised to $146 from $143 at UBS by TipRanks Oct 17 7:12am ET Abbott price target raised to $133 from $131 at Piper Sandler by TipRanks Oct 17 6:48am ET Goldman Sachs Remains a Buy on Abbott Laboratories (ABT) by TipRanks Oct 17 6:48am ET Abbott Laboratories (ABT) Gets a Buy from Piper Sandler by TipRanks Oct 17 6:46am ET RBC Capital Keeps Their Buy Rating on Abbott Laboratories (ABT) by TipRanks Oct 17 6:41am ET Abbott price target raised to $138 from $133 at Bernstein by TipRanks Oct 17 6:32am ET Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Abbott Laboratories (ABT) by TipRanks Oct 17 6:31am ET Travis Steed Reiterates Buy Rating on Abbott Laboratories Amid Promising Growth and Under-Ownership Potential by TipRanks Oct 17 6:29am ET Abbott Laboratories: Strong Buy Rating Driven by Robust Growth Prospects and Operational Improvements by TipRanks Oct 17 5:36am ET Abbott Laboratories: Buy Rating Reaffirmed Amid Strong Medical Device Performance and Positive Long-Term Growth Outlook by TipRanks

Nov 27 6:24pm ET Top Research Reports for Abbott, BlackRock & ConocoPhillips by Zacks Nov 27 2:01pm ET ABT Stock Benefits From First Patient Procedures With TAVI System by Zacks Nov 25 4:40pm ET PAHC vs. ABT: Which Stock Is the Better Value Option? by Zacks Nov 22 4:30pm ET Why Is Boston Scientific (BSX) Up 7.5% Since Last Earnings Report? by Zacks Nov 22 3:15pm ET PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US by Zacks Nov 20 2:00pm ET Is Trending Stock Abbott Laboratories (ABT) a Buy Now? by Zacks Nov 19 2:30pm ET Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy? by Zacks Nov 13 3:28pm ET Hims & Hers Stock Gains 31.1% Since Q3 Earnings: What's Next? by Zacks Nov 08 1:13pm ET The Zacks Analyst Blog Highlights like Amazon.com, Procter & Gamble, Abbott and NVE by Zacks Nov 07 9:20pm ET Top Stock Reports for Amazon.com, Procter & Gamble & Abbott by Zacks Nov 07 4:40pm ET PAHC or ABT: Which Is the Better Value Stock Right Now? by Zacks Nov 07 4:10pm ET Medtronic Stock Trading at a Discount Before Q2 Earnings: Time to Buy? by Zacks Nov 05 2:00pm ET Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know by Zacks Oct 31 11:20am ET Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? by Zacks Oct 29 3:43pm ET AngioDynamics Stock Plunges 13.8% in Three Months: What's Next? by Zacks Oct 29 3:28pm ET Here's Why You Should Retain ABT Stock in Your Portfolio Now by Zacks Oct 29 1:07pm ET ABT's New Trial on Advanced Heart Failure Outcomes Set to Boost Stock by Zacks Oct 25 5:25pm ET HCA Healthcare Beats on Q3 Earnings, Reaffirms 2024 EPS View by Zacks Oct 24 6:37pm ET Molina Healthcare Q3 Earnings Beat Estimates on Growing Premiums by Zacks Oct 24 6:29pm ET Community Health Q3 Earnings Miss on Lower Adjusted Admissions by Zacks Oct 23 5:20pm ET Growing Biosimilars Business Supports ABT Stock, Macro Issues Hurt by Zacks Oct 23 2:00pm ET Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It by Zacks Oct 21 9:52pm ET Top Research Reports for Visa, Netflix & Merck by Zacks Oct 21 4:40pm ET MDT vs. ABT: Which Stock Is the Better Value Option? by Zacks

1-year income & revenue

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Target expects a sluggish holiday season.

David Paul Morris/Bloomberg/Getty Images

Target sounds the alarm bell on holiday shopping

Investors piled into safe havens like gold and US debt as tensions rose in Europe. Gold prices jumped on Tuesday and US Treasury rates dipped.

Angela Weiss/AFP/Getty Images

Stocks shrug off concerns about heightened US-Russia tensions

A lone shopper places items in her cart in the frozen food aisle of a Walmart store Thursday, Nov. 14, 2024, in Englewood, Colo.

David Zalubowski/AP

As Americans bargain shop, six-figure earners flock to Walmart

NEW YORK, NEW YORK - JULY 07: Bikes with Grubhub bags sit on the street on July 07, 2023 in New York City. Grubhub, DoorDash and Uber Eats sued the City of New York on July 6th in order to block its new minimum pay rules for food delivery workers. (Photo by Leonardo Munoz/VIEWpress)

Leonardo Munoz/VIEWpress/Getty Images

Grubhub just sold for $650 million. Four years ago it was worth $7.3 billion